Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACKR3 | P25106 | 17/20 | 0.64 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4430258 | 0.89 | ACKR3 (0.70) | ACKR3HDAC1 | |
| SCHEMBL1891586 | 0.84 | ACKR3 (0.68) | ACKR3HDAC1 | |
| SCHEMBL8288790 | 0.83 | ACKR3 (0.59) | ACKR3HDAC1 | |
| SCHEMBL4420253 | 0.81 | ACKR3 (0.67) | ACKR3HDAC1 | |
| SCHEMBL4421213 | 0.81 | ACKR3 (0.56) | ACKR3HDAC1 | |
| SCHEMBL31687502 | 0.78 | ACKR3 (1.00) | ACKR3 | |
| SCHEMBL1885991 | 0.77 | ACKR3 (0.72) | ACKR3HDAC1 | |
| SCHEMBL14260725 | 0.77 | HDAC1 (0.56) | ACKR3HDAC1 | |
| SCHEMBL1885544 | 0.77 | HDAC1 (0.67) | ACKR3HDAC1 | |
| SCHEMBL31687518 | 0.76 | ACKR3 (1.00) | ACKR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070167499-A1 | Biaryl linked hydroxamates: preparation and pharmaceutical applications | A*BIO PTE LTD. (SG) | 2007-07-19 | — | — | US | disclosed |
| US-20070167499-A1 | Biaryl linked hydroxamates: preparation and pharmaceutical applications | A*BIO PTE LTD. (SG) | 2007-07-19 | — | — | US | disclosed |
| WO-2005040161-A1 | BIARYL LINKED HYDROXAMATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS | S*BIO PTE LTD (SG) | 2005-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167499-A1 | Biaryl linked hydroxamates: preparation and pharmaceutical applications | HDAC1, HDAC11, HDAC2 | ACKR3 3189/4885HDAC1 1/4885TP53 1423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.